The Future of Psychedelic Access in Canada: PsyCan Releases White Paper Reviewing Regulatory Options for Psychedelics
03 oct. 2023 07h00 HE
|
Psychedelics Canada
PsyCan, the trade association for the for-profit psychedelic medicine industry, releases a white paper on how Health Canada can improve access to therapies
Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program
07 sept. 2023 07h30 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly...
Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)
05 janv. 2022 16h17 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...